Lavinia Spain
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 40
- Cancer Immunotherapy and Biomarkers 31
- CAR-T cell therapy research 12
- Colorectal Cancer Treatments and Studies 9
-
- Prostate Cancer Treatment and Research 15
- Renal cell carcinoma treatment 7
- Brain Metastases and Treatment 7
- Co-authors
- James LarkinStefan DiemMartin GoreSamra TurajlicKarin JordanCaroline RobertWolfgang WickMichel Obéid
- Journals
- Annals of Oncology (8 papers)Journal of Clinical Oncology (6 papers)ESMO Open (3 papers)European Journal of Cancer (2 papers)Value in Health (2 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Lavinia Spain
58 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 1.9k
- Immunology 464
- Genetics 213
- Pulmonary and Respiratory Medicine 646
- Transplantation 35
Countries citing papers authored by Lavinia Spain
This map shows the geographic impact of Lavinia Spain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lavinia Spain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lavinia Spain more than expected).
Fields of papers citing papers by Lavinia Spain
This network shows the impact of papers produced by Lavinia Spain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lavinia Spain. The network helps show where Lavinia Spain may publish in the future.
Co-authors
The 25 scholars most cited alongside Lavinia Spain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 12 | |
| 5 | 2022 | 0 | |
| 6 | 2021 | 8 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 14 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 10 | |
| 11 | 2019 | 1 | |
| 12 | 2019 | 35 | |
| 13 | 2018 | 0 | |
| 14 | 2016 | 118 | |
| 15 | 2016 | 198 | |
| 16 | 2016 | 5 | |
| 17 | 2016 | 29 | |
| 18 | Management of toxicities of immune checkpoint inhibitors Hit paper breakdown → | 2016 | 660 |
| 19 | 2015 | 4 | |
| 20 | 2012 | 1 |
About Lavinia Spain
Lavinia Spain is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 61 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (31 papers), Prostate Cancer Treatment and Research (15 papers), CAR-T cell therapy research (12 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Melanoma and MAPK Pathways (8 papers), Renal cell carcinoma treatment (7 papers) and Brain Metastases and Treatment (7 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (464 citations), Genetics (213 citations), Pulmonary and Respiratory Medicine (646 citations) and Transplantation (35 citations). Lavinia Spain has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include James Larkin, Stefan Diem, Martin Gore, Samra Turajlic, Karin Jordan, Caroline Robert, Wolfgang Wick, Michel Obéid, Solange Peters and John B.A.G. Haanen. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, ESMO Open, European Journal of Cancer and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.